首页|狂犬病疫苗接种后偶合过敏性紫癜1例

狂犬病疫苗接种后偶合过敏性紫癜1例

扫码查看
受种儿童于2022年6月4日9时、6月7日14时,先后在某卫生院预防接种门诊接种人用狂犬病疫苗(Vero细胞)第一剂次、第二剂次.在2022年6月8日至7月5日先后在四家医院诊断为过敏性紫癜(HSP);2022年10月21日调查了该儿童接种狂犬病疫苗后发生的HSP事件与接种疫苗之间的关联性.对患儿出生至今免疫规划相关接种资料以及该种类疫苗生产企业资质和产品质量合格证明、批号、疫苗进货渠道、供货单位的资质证明等进行查询.开展疑似预防接种异常反应(AEFI)调查,调查诊断意见为"不属于AEFI".接种狂犬病疫苗后发生的HSP事件与接种疫苗之间无关联,属于偶合症.
A case of Henoch-Schonlein purpura after rabies vaccination
At 9:00 on June 4,2022 and 14:00 on June 7,2022,a child was inoculated with the first dose and the second dose of human rabies vaccine(Vero cells)in the vaccination clinic of a health center.From June 8 to July 5,2022,the child was diagnosed as Henoch-Schonlein purpura(HSP)in four hospitals.On October 21,2022,the correlation between the HSP occurred after this child was vaccinated with rabies vaccine and the vaccine was investigated.The vaccination data related to the immunization program since the birth of the child,as well as the qualification of the vaccine manufacturer and the product quality certificate,batch number,vaccine purchasing channel and qualification certificate of the supplier were inquired.Investigation on the suspected adverse events following immunization(AEFI)was carried out,and the diagnosis comment of the investigation was"non-AEFI".The HSP event after rabies vaccination is unrelated to the vaccine,which belongs to coincidental illness.

Henoch-Schonlein purpuraVaccinationCoincidental illnessAdverse events following immunization

郭帅志、侯敏、李伟健、陶泽新

展开 >

山东省菏泽市疾病预防控制中心计划免疫科,山东菏泽 274000

山东省疾病预防控制中心计划免疫所,山东济南 250014

过敏性紫癜 疫苗接种 偶合症 预防接种异常反应

2024

中国医药科学
海峡两岸医药卫生交流协会 二十一世纪联合创新(北京)医药科学研究院

中国医药科学

影响因子:1.083
ISSN:2095-0616
年,卷(期):2024.14(18)